Smoking, alcohol consumption may lead to prolonged feeding tube use in head and neck cancer
the ONA take:
A recent study found that current smoking and heavy alcohol consumption appear to be risk factors for prolonged use of a gastrostomy tube (GT) in patients with head and neck squamous cell carcinoma (SCC) undergoing radiotherapy or chemoradiotherapy.
This study included patients with head and neck SCC undergoing treatment at a teaching hospital in Ireland; 84 patients were undergoing chemoradiation and 20 patients, radiotherapy alone.
The median duration of GT use was 9 months, and GT use at 12 months was 35%. Risk factors for prolonged GT use was current heavy alcohol consumption and current smoking; however, multivariate analyses showed only current smoking to be an independent risk factor.
The researchers hypothesize that several reasons may explain why smoking and drinking might have an effect. Nicotine may suppress appetite and heavy alcohol consumption may lead to poor motivation to resume eating after treatment.
Further studies would be needed to determine if stopping smoking and drinking can shorten duration of GT use.
Smoking and alcohol consumption are risk factors for use of a gastrostomy tube in head and neck squamous cell carcinoma (SCC).
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- PPIs Negatively Impact Outcomes of Patients Treated With Capecitabine
- How Physical Changes From Breast Cancer Affect Self-Image: Considerations for Clinicians
- Clinical Use of Cabozantinib in the Treatment of Advanced Kidney Cancer: Efficacy, Safety, and Patient Selection
- Panobinostat Modestly Improves OS in Relapsed Multiple Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Pseudohyperkalemia: False Potassium Levels Occur in a Patient With Lymphoma
- Atezolizumab Granted FDA Approval for Specific Cases of NSCLC
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- High U.S. Economic Burden for Vaccine-Preventable Diseases
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|